{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Eatontown",
      "state": "NJ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "64107",
      "recalling_firm": "West-ward Pharmaceutical Corp.",
      "address_1": "465 Industrial Way W",
      "address_2": "N/A",
      "postal_code": "07724-2209",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-170-2013",
      "product_description": "Belladonna Alkaloids (hyoscyamine sulfate, USP 0.1037 mg; atropine sulfate, USP 0.0194 mg; scopolamine HBr, USP 0.0065 mg) with Phenobarbital (USP 16.2 mg) Tablets, packaged in a) 1000-count tablets per bottle (NDC 0143-1140-10; b) 5000-count tablets per bottle (NDC 143-1140-51); Rx only,  Manufactured by: West-ward Pharmaceutical Corp. Eatontown, NJ 07724",
      "product_quantity": "6,511 bottles",
      "reason_for_recall": "Presence of Foreign Substance: Uncharacteristic blacks spots were found in tablets.",
      "recall_initiation_date": "20130107",
      "center_classification_date": "20130227",
      "termination_date": "20150121",
      "report_date": "20130306",
      "code_info": "Lot #: 69099A, 69099B, Exp 08/15"
    }
  ]
}